Search clinical trials for: Breast Neoplasm

Total 109126 results

Institut Curie
Roche Pharma AG; Replimune Inc.

Not yet recruiting

"neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer (neoBREASTIM)

Triple Negative Breast Neoplasms

France
Hoffmann-La Roche

Recruiting

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

Belgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Guatemala, Hungary, Indi...
Lebanese University
Haykel Hospital

Recruiting

Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms (CAT_PB)

Cardiovascular Diseases | Immune System Diseases | Cancer | Breast Cancer | Hepatocellular Carcinoma | Lung Cancer | Chemotherapy | Solid Tumor | Prostate Cancer | Thromboembolism | Colon Cancer | Immunotherapy | Inflammatory Diseases

Lebanon
Tango Therapeutics, Inc.

Recruiting

Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors

Breast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian Cancer

United States
Forward Pharmaceuticals Co., Ltd.

Recruiting

A Phase I Clinical Trial of FWD1802 in Patients With ER+/HER2- BC.

Metastatic Breast Cancer | Breast Cancer Stage I | Locally Advanced Breast Cancer | ER+ Breast Cancer

China
Northwestern University
National Cancer Institute (NCI)

Not yet recruiting

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Estrogen-receptor-positive Breast Cancer | HER2/Neu-Negative Breast Cancer | Advanced Breast Cancerv

United States
Zuyderland Medisch Centrum
Hologic, Inc.

Recruiting

Contrast-Enhanced Stereotactic Biopsy (CESB)

Breast Cancer | Breast Neoplasms | Breast Cancer Female

Netherlands
Herlev and Gentofte Hospital
University of Aarhus; Danish Cancer Society; The Novo Nordic Foundation; University...

Recruiting

Personalized Breast Cancer Screening (PRSONAL)

Breast Cancer

Denmark
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Treatment of Insomnia in Patients With Breast Cancer

Breast Cancer | Insomnia

Italy
I.M. Sechenov First Moscow State Medical University

Recruiting

Non-contrast Magnetic Resonance Angiography in Deep Inferior Epigastric Perforator Flap Breast Reconstruction Planning

Breast Cancer | Postsurgical Acquired Absence of Organ

Russian Federation
Universitätsklinikum Hamburg-Eppendorf

Recruiting

Digital Tool Enhancing GPs' Information Management for Patients With Multimorbidity - a Pilot Study (gp-multitool)

Coronary Disease | Diabetes Mellitus, Type 2 | Breast Neoplasms | Diabetes Mellitus, Type 1 | Pulmonary Disease, Chronic Obstructive | Asthma | Comorbidities and Coexisting Conditions

Germany
Mayo Clinic

Recruiting

Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy

Breast Carcinoma

United States
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer

HER2-PositiveRecurrent or Metastatic Breast Cancer
International Agency for Research on Cancer
Malabar Cancer Care Society Kannur, India; Bhabha Atomic Research Centre (BARC)...

Recruiting

Handheld Ultrasound Device to Triage Women With a Positive Clinical Breast Examination by Trained Non-radiologists (PUD)

Carcinoma in Situ | Breast Cancer

India
Mayo Clinic

Recruiting

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy (BOSS)

Breast Carcinoma

United States
University of Hail

Recruiting

Exercises Using Virtual Reality on Cancer Patients

Breast Cancer Female

Saudi Arabia
University of California, San Francisco

Recruiting

Heart Health After Cancer Treatment (HEART-ACT)

Breast Cancer

United States
National Cancer Institute (NCI)

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast Carcinoma

United States
Mayo Clinic

Recruiting

Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

Breast Neoplasm

United States
Centre Henri Becquerel

Not yet recruiting

Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation (MBRESC)

Breast Neoplasm

France
Jules Bordet Institute

Recruiting

PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer. (PRISMA)

TNBC - Triple-Negative Breast Cancer

Belgium
University of Santiago de Compostela
Fundacin Biomedica Galicia Sur

Recruiting

Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP) (ONCODEP)

Cognitive Impairment | Depressive Symptoms

Spain
MGH Institute of Health Professions

Recruiting

Strength After Breast Cancer (SABC)

Breast Cancer

United States
Bolt Biotherapeutics, Inc.

Recruiting

Study of BDC-3042 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Malignancies

Clear Cell Renal Cell Carcinoma | Head and Neck Cancer | Colorectal Cancer | Ovarian Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer

United States
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology (SAHARA-04)

Breast Cancer

France
Hacettepe University

Recruiting

Investigation of the Efficiency of Pain Neuroscience Education in Patients With Chronic Pain After Breast Cancer Surgery

Breast Cancer

Turkey
Theodoros Foukakis
Karolinska Institutet; Centre for Research and Technology Hellas (CERTH)

Recruiting

Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes (CIPN-REBECCA)

Quality of Life | Breast Cancer | Breast Neoplasms | Chemotherapy-induced Peripheral Neuropathy | Early-stage Breast Cancer | Non-Metastatic Breast Carcinoma | Polyneuropathy Due to Drugs | Polyneuropathy; Drug

Sweden
Zuyderland Medisch Centrum

Recruiting

Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors (CEMMAG)

Breast Cancer

Netherlands
Hacettepe University

Recruiting

The Effect of Simulation-Based Breast Health Education on Breast Cancer Awareness and Breast Self-Examination Practices

Breast Cancer | Health Knowledge, Attitudes, Practice

Turkey
Hongmei Zheng

Recruiting

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Endocrine Therapy | Breast Cancer Female

China
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Recruiting

EMBRACE: Exercising Together

Breast Carcinoma | Prostate Carcinoma

United States
Datar Cancer Genetics Inc

Recruiting

Early Detection of Breast Cancer

Breast Neoplasms

United States
Kaohsiung Veterans General Hospital.

Recruiting

Early Diagnosis of Breast Cancer-related Lymphedema

Lymphedema

Taiwan
Sichuan Enray Pharmaceutical Sciences Company

Recruiting

Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor (CNSI-Fe(II))

Cervical Cancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Pancreas Cancer | Thyroid Cancer | Vulva Cancer

China
Region Örebro County
Helsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaborators

Recruiting

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients (IMPORTANT)

Quality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older Patients

Sweden, Finland, Greece, Italy, Norway, Spain
Sichuan Baili Pharmaceutical Co., Ltd.

Recruiting

A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer

Breast Cancer

China
Chongqing Precision Biotech Co., Ltd
Zhejiang University

Recruiting

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Breast Cancer | Gastric Cancer | Colorectal Cancer | Bile Duct Cancer | Non-small Cell Lung Cancer | Pancreas Cancer | Esophagus Cancer

China
Galzu Institute of Research, Teaching, Science...
Hospital Santa Casa de Misericordia de Campos; Hospital Escola Alvaro Alvim; Universidade...

Not yet recruiting

Vascular Supply Identification, Lesion Extension and Search for Tumor Similarity at a Distance by VTM in Breast Cancer

Breast Cancer Female
MedSIR
Daiichi Sankyo

Not yet recruiting

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases (TUXEDO-4)

Breast Cancer | Metastatic Breast Cancer
Hospital Clinico Universitario de Santiago
Hospital Arquitecto Marcide

Not yet recruiting

Nutritional Intervention-induced Weight Loss During the Oncological Treatment of Obesity-related Breast Cancer (NUTOBREST)

Obesity | Breast Cancer | Weight Change, Body | Epigenetic Disorder
Istituti Clinici Scientifici Maugeri SpA
Carlo Morasso

Recruiting

Circulating Tumour Cells Characterization in Breast Cancer Patients (BioCellPhe)

Breast Cancer

Italy
China Medical University Hospital

Not yet recruiting

Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing

Breast Cancer | Radiation Dermatitis
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma

United States
Nova Scotia Health Authority
Obafemi Awolowo University

Not yet recruiting

De-escalating Axillary Surgery in Breast Cancer Patients in Nigeria

Breast Cancer | Axilla; Breast
GenMont Biotech Incorporation
Mackay Memorial Hospital

Recruiting

To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

Breast Cancer

Taiwan
Biocon Biologics UK Ltd

Not yet recruiting

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Mayo Clinic

Recruiting

CARE: Cancer Risk Perception and Women of Color

Breast Carcinoma

United States
Air Force Military Medical University, China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; The First Affiliated... and other collaborators

Recruiting

Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing

Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreas Cancer | Liver Cancer | Esophagus Cancer | Cancer Diagnosis | LungCancer

China
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Recruiting

A Study of Mental Health Care in People With Cancer

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer

United States
Hunan Cancer Hospital

Not yet recruiting

Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

Breast Cancer | Endocrine Therapy | CDK4/6 Inhibitors | Subsequent Treatment

Search clinical trials for: Breast Neoplasm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations